We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
JAMA Patient Page |

Kidney Cancer FREE

Janet M. Torpy, MD, Writer; Cassio Lynm, MA, Illustrator; Richard M. Glass, MD, Editor
JAMA. 2004;292(1):134. doi:10.1001/jama.292.1.134.
Text Size: A A A
Published online

Cancer of the kidneys, also known as renal cancer, can be cured if detected early. However, symptoms may not occur until the tumor has become large or metastasized (spread to other organs), when it is difficult to treat. The majority of kidney cancers are renal cell carcinomas, also known as renal adenocarcinomas or clear cell carcinomas. Most kidney cancers affect adults between 50 and 70 years of age. The most common type of kidney cancer in children is called Wilms tumor. The July 7, 2004, issue of JAMA includes an article about renal cancer.


  • Kidney cancers most commonly occur in adults older than 50 years.

  • Men are twice as likely to have renal cancers as women are.

  • Cigarette smoking increases the risk of developing renal cell cancer.

  • Environmental and occupational exposures to asbestos, cadmium, and organic solvents increase the risk of developing kidney cancer.

  • Obesity and eating a high-fat diet have been linked with as many as 20% of kidney cancers.

  • von Hippel-Lindau disease is a genetic condition that has a high incidence of kidney cancer.


  • Hematuria (blood in the urine)

  • Abdominal or low back pain unrelated to injury

  • Unintentional weight loss

  • Fatigue

  • Anemia (low red blood cell count)

  • Fever

  • High blood pressure

  • Leg or ankle swelling


Diagnosis of renal cancer may involve several kinds of tests. In addition to a detailed medical history, physical examination, and laboratory blood testing, tests may include a computed tomography (CT) scan, ultrasound, magnetic resonance imaging (MRI), or intravenous pyelography (a dye and x-ray test of the kidneys). Chest x-ray and bone scan may be used to detect metastatic disease. Arteriography, a technique that uses dye in the blood vessels feeding the kidney, may define the extent of the tumor or help plan surgical treatment.


Surgical removal of the kidney (nephrectomy) and surrounding tissue may cure kidney cancer in persons whose tumor is confined to the kidney. Radiation therapy (high-energy x-ray treatments) may be offered to patients to treat pain and advanced or metastatic kidney cancers or to help shrink a tumor that is causing obstruction. Immunotherapy helps to boost the body's own immune system to fight the cancer. Interferon and interleukin 2 boost the immune system and may be used to treat patients with advanced kidney cancer. Patients who volunteer for clinical trials (medical research studies) may be offered immunotherapy in combination with experimental treatments.



To find this and previous JAMA Patient Pages, go to the Patient Page link on JAMA's Web site at http://www.jama.com. Many are available in English and Spanish. A Patient Page on preventing cancer was published in the May 26, 2004, issue; and one on cancer clinical trials was published in the June 9, 2004, issue.

Sources: American Cancer Society, National Cancer Institute

The JAMA Patient Page is a public service of JAMA. The information and recommendations
appearing on this page are appropriate in most instances, but they are not a substitute for medical diagnosis. For specific information concerning your personal medical condition, JAMA suggests that you consult your physician. This page may be photocopied noncommercially by physicians and other health care professionals to share with patients. Any other print or online reproduction is subject to AMA approval. To purchase bulk reprints, call 718/946-7424.




Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Collections
PubMed Articles